Brief: SELLAS Life Sciences FY Net Income USD -30.881 Million
20/03/2025 20:05
Mar 20 (Reuters) - SELLAS Life Sciences FY operating income USD -31.513 million. FY operating expenses USD 31.513 million FY basic EPS USD -0.5
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses